$VNDA
Vanda Pharmaceuticals Inc.

2013 Q4 Form 10-Q Financial Statement

#000119312513433952 Filed on November 08, 2013

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2012 Q4
Revenue $8.783M $8.709M $7.920M
YoY Change 10.9% 5.08% -5.38%
Cost Of Revenue $130.0K
YoY Change
Gross Profit $7.790M
YoY Change -6.93%
Gross Profit Margin 98.36%
Selling, General & Admin $9.930M $5.741M $3.230M
YoY Change 207.43% 82.25% -3.58%
% of Gross Profit 41.46%
Research & Development $6.270M $8.022M $10.62M
YoY Change -40.96% -21.04% 0.57%
% of Gross Profit 136.33%
Depreciation & Amortization $500.0K $500.0K $500.0K
YoY Change 0.0% 0.0% -16.67%
% of Gross Profit 6.42%
Operating Expenses $16.57M $13.76M $14.22M
YoY Change 16.53% 35.48% -0.42%
Operating Profit -$7.791M -$5.431M -$6.428M
YoY Change 21.2% 0.67% 8.8%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $40.00K $30.00K $60.00K
YoY Change -33.33% -57.14% -40.0%
Pretax Income -$7.750M -$5.380M -$6.370M
YoY Change 21.66% 1.01% 9.64%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$7.747M -$5.406M -$6.369M
YoY Change 21.64% 1.5% 15.32%
Net Earnings / Revenue -88.2% -62.07% -80.42%
Basic Earnings Per Share -$0.23 -$0.17 -$0.23
Diluted Earnings Per Share -$0.23 -$0.17 -$0.23
COMMON SHARES
Basic Shares Outstanding 33.19M shares 31.33M shares
Diluted Shares Outstanding 31.33M shares

Balance Sheet

Concept 2013 Q4 2013 Q3 2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $130.4M $142.2M $120.4M
YoY Change 8.26% 5.8% -19.13%
Cash & Equivalents $64.76M $142.2M $88.77M
Short-Term Investments $65.59M $0.00 $31.63M
Other Short-Term Assets $128.0K $2.900M $4.400M
YoY Change -97.09% -23.68% 46.67%
Inventory $0.00 $0.00 $57.00K
Prepaid Expenses
Receivables $2.031M $1.956M $1.168M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $135.6M $147.1M $126.0M
YoY Change 7.66% 5.13% -17.94%
LONG-TERM ASSETS
Property, Plant & Equipment $2.198M $2.106M $2.348M
YoY Change -6.39% -12.25% 143.57%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $500.0K $500.0K $600.0K
YoY Change -16.67% -16.67% 614.29%
Total Long-Term Assets $7.735M $8.020M $9.480M
YoY Change -18.41% -18.99% -67.44%
TOTAL ASSETS
Total Short-Term Assets $135.6M $147.1M $126.0M
Total Long-Term Assets $7.735M $8.020M $9.480M
Total Assets $143.3M $155.1M $135.4M
YoY Change 5.83% 3.53% -25.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $661.0K $369.0K $287.0K
YoY Change 130.31% -66.45% -71.18%
Accrued Expenses $5.180M $4.532M $5.187M
YoY Change -0.13% -33.35% 53.42%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $32.85M $31.91M $32.26M
YoY Change 1.82% -7.79% 2.04%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $66.40M $73.20M $93.30M
YoY Change -28.83% -26.65% -20.6%
Total Long-Term Liabilities $66.40M $73.20M $93.30M
YoY Change -28.83% -26.65% -20.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $32.85M $31.91M $32.26M
Total Long-Term Liabilities $66.40M $73.20M $93.30M
Total Liabilities $99.23M $105.1M $125.5M
YoY Change -20.96% -21.87% -15.82%
SHAREHOLDERS EQUITY
Retained Earnings -$308.2M -$303.7M -$291.1M
YoY Change 5.86% 10.5%
Common Stock $352.3M $353.7M $301.0M
YoY Change 17.03% 1.38%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $44.12M $50.00M $9.905M
YoY Change
Total Liabilities & Shareholders Equity $143.3M $155.1M $135.4M
YoY Change 5.83% 3.53% -25.83%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2012 Q4
OPERATING ACTIVITIES
Net Income -$7.747M -$5.406M -$6.369M
YoY Change 21.64% 1.5% 15.32%
Depreciation, Depletion And Amortization $500.0K $500.0K $500.0K
YoY Change 0.0% 0.0% -16.67%
Cash From Operating Activities -$12.20M -$10.20M -$13.80M
YoY Change -11.59% 0.0% 12.2%
INVESTING ACTIVITIES
Capital Expenditures -$100.0K $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities -$65.60M $0.00 -$1.900M
YoY Change 3352.63% -100.0% -104.75%
Cash From Investing Activities -$65.70M $0.00 -$1.900M
YoY Change 3357.89% -100.0% -104.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $48.50M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 500.0K 48.80M 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -12.20M -10.20M -13.80M
Cash From Investing Activities -65.70M 0.000 -1.900M
Cash From Financing Activities 500.0K 48.80M 0.000
Net Change In Cash -77.40M 38.60M -15.70M
YoY Change 392.99% 282.18% -156.88%
FREE CASH FLOW
Cash From Operating Activities -$12.20M -$10.20M -$13.80M
Capital Expenditures -$100.0K $0.00 $0.00
Free Cash Flow -$12.10M -$10.20M -$13.80M
YoY Change -12.32% 0.0% 13.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
33190106 shares
CY2011Q3 vnda Lease Occupancy
LeaseOccupancy
21400 sqft
CY2012Q3 us-gaap Deferred Revenue
DeferredRevenue
123816000
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
104515000
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33190106 shares
CY2013Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2013Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
11.14
CY2013Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33190106 shares
CY2013Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
70238000
CY2013Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
316000
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
31905000
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
6321000
CY2013Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1304000
CY2013Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
27000
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
11007000
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
369000
CY2013Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1060000
CY2013Q3 us-gaap Restructuring Reserve
RestructuringReserve
59000
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1106000
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
50002000
CY2013Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
353708000
CY2013Q3 us-gaap Deferred Revenue
DeferredRevenue
97027000
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-303739000
CY2013Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
26789000
CY2013Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4532000
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1052000
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1133000
CY2013Q3 us-gaap Liabilities
Liabilities
105088000
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1079000
CY2013Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6586000
CY2013Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
2945000
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
33000
CY2013Q3 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
215000
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
155090000
CY2013Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
530000
CY2013Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
500000
CY2013Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
2099000
CY2013Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
2400000
CY2013Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1956000
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1495000
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1495000
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
377000
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2106000
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
552000
CY2013Q3 us-gaap Assets
Assets
155090000
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
142172000
CY2013Q3 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
10000
CY2013Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5414000
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1495000
CY2013Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
12000000
CY2013Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2412000
CY2013Q3 us-gaap Prepaid Insurance
PrepaidInsurance
303000
CY2013Q3 us-gaap Assets Current
AssetsCurrent
147070000
CY2013Q3 vnda Number Of Stock Incentive Plans
NumberOfStockIncentivePlans
2 EquityPlan
CY2013Q3 vnda Accrued Research And Development Expense
AccruedResearchAndDevelopmentExpense
2082000
CY2013Q3 vnda Liabilities Recorded Future License Payments
LiabilitiesRecordedFutureLicensePayments
0
CY2013Q3 vnda Liabilities Recorded Contractual Obligations Relating To License Agreements
LiabilitiesRecordedContractualObligationsRelatingToLicenseAgreements
0
CY2011Q4 us-gaap Restructuring Reserve
RestructuringReserve
740000
CY2011Q4 us-gaap Deferred Revenue
DeferredRevenue
143853000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
87923000
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28241743 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28241743 shares
CY2012Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
90275000
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
32263000
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
127000
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
321000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
287000
CY2012Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
386000
CY2012Q4 us-gaap Restructuring Reserve
RestructuringReserve
453000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
9905000
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
300974000
CY2012Q4 us-gaap Deferred Revenue
DeferredRevenue
117064000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-291107000
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
26789000
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5187000
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
10000
CY2012Q4 us-gaap Liabilities
Liabilities
125543000
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5468000
CY2012Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
3005000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
28000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
135448000
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
430000
CY2012Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
31631000
CY2012Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
31621000
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
600000
CY2012Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
3479000
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1168000
CY2012Q4 us-gaap Inventory Net
InventoryNet
57000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2348000
CY2012Q4 us-gaap Assets
Assets
135448000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
88772000
CY2012Q4 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
276000
CY2012Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6532000
CY2012Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
31631000
CY2012Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
12000000
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3967000
CY2012Q4 us-gaap Prepaid Insurance
PrepaidInsurance
155000
CY2012Q4 us-gaap Assets Current
AssetsCurrent
125968000
CY2012Q4 vnda Reversal Of Deferred Rent
ReversalOfDeferredRent
500000
CY2012Q4 vnda Accrued Research And Development Expense
AccruedResearchAndDevelopmentExpense
3900000
CY2012Q4 vnda Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
10000
CY2012Q4 vnda Availableforsale Equity Securities Gross Unrealized Loss Accumulated In Investments
AvailableforsaleEquitySecuritiesGrossUnrealizedLossAccumulatedInInvestments
dei Trading Symbol
TradingSymbol
VNDA
dei Entity Registrant Name
EntityRegistrantName
Vanda Pharmaceuticals Inc.
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
dei Entity Central Index Key
EntityCentralIndexKey
0001347178
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.43
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0128 pure
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.43
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29363162 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
shares
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
4680000 shares
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P8Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y11D
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
49520 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.98
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-27439000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4556838 shares
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-TOP: 18pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> <b><i>Use of estimates</i></b></p> <p style="MARGIN-TOP: 6pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The preparation of financial statements in conformity with GAAP requires management to make estimates that affect the reported amounts of assets and liabilities at the date of the financial statements, disclosure of contingent assets and liabilities, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> </div>
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y8M12D
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29363162 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.63 pure
us-gaap Restructuring Charges
RestructuringCharges
10000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3227000
us-gaap Payments For Restructuring
PaymentsForRestructuring
384000
us-gaap Sales Revenue Net
SalesRevenueNet
25096000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
48552000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
79000
us-gaap License And Services Revenue
LicenseAndServicesRevenue
20037000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
-10000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12632000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-121000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
196000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
788000
us-gaap Other Income
OtherIncome
101000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1062000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1555000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12642000
us-gaap Operating Income Loss
OperatingIncomeLoss
-12733000
us-gaap Royalty Revenue
RoyaltyRevenue
5059000
us-gaap Net Income Loss
NetIncomeLoss
-12632000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-10000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3321000
us-gaap Costs And Expenses
CostsAndExpenses
37829000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14743000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
49418000
us-gaap Share Based Compensation
ShareBasedCompensation
3321000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
53400000
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
196000
us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
1062000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-20037000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-655000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
82000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
48552000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
155000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
321000
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1118000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
31500000
us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
20037000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
800000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
31421000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21968000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
600000
vnda Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Share Subject To Option Awards
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfShareSubjectToOptionAwards
0.25 pure
vnda Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Unissued In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndUnissuedInPeriodTotalFairValue
400000
vnda Share Based Compensation Arrangement By Share Based Payment Award Remaining Percentage Of Share Subject To Option Awards
ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingPercentageOfShareSubjectToOptionAwards
0.75 pure
vnda Initial Stock Options Granted To Directors Vesting And Exercisable Period
InitialStockOptionsGrantedToDirectorsVestingAndExercisablePeriod
P4Y
vnda Sharebased Compensation Arrangement By Sharebased Payment Award Restricted Stock Units Or Non Vested Shares Vesting Period1
SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockUnitsOrNonVestedSharesVestingPeriod1
P4Y
vnda Optional Lease Termination Year
OptionalLeaseTerminationYear
2023
vnda Vesting Period
VestingPeriod
P4Y
vnda Subsequent Stock Options Granted To Directors Vesting And Exercisable Period
SubsequentStockOptionsGrantedToDirectorsVestingAndExercisablePeriod
P1Y
vnda Share Based Compensation Option Awards Contractual Term
ShareBasedCompensationOptionAwardsContractualTerm
P10Y
vnda Option Awards Vesting Period After Completion Of One Year Of Service
OptionAwardsVestingPeriodAfterCompletionOfOneYearOfService
P3Y
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.75
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0104 pure
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.75
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28226743 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y11D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.71
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21295000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-416000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-31068000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5184757 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28226743 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.68 pure
us-gaap Sales Revenue Net
SalesRevenueNet
24807000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2010000
us-gaap License And Services Revenue
LicenseAndServicesRevenue
20037000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
49967000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
2000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-83000
us-gaap Other Income
OtherIncome
502000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
401000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21293000
us-gaap Operating Income Loss
OperatingIncomeLoss
-21797000
us-gaap Royalty Revenue
RoyaltyRevenue
4770000
us-gaap Net Income Loss
NetIncomeLoss
-21295000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2000
us-gaap Costs And Expenses
CostsAndExpenses
46604000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10657000
us-gaap Share Based Compensation
ShareBasedCompensation
3171000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
16592000
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
2497000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-20037000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3372000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
94000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
57000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
528000
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1118000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
97140000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3155000
us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
20037000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1800000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
47660000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
34829000
vnda Landlord Contributions For Tenant Improvements
LandlordContributionsForTenantImprovements
1826000
CY2011Q3 us-gaap Lessee Leasing Arrangements Operating Leases Renewal Term
LesseeLeasingArrangementsOperatingLeasesRenewalTerm
P5Y
CY2013Q3 vnda Allowance For Tenant Improvements
AllowanceForTenantImprovements
1900000
CY2006 vnda Milestone Payment Under License Agreement
MilestonePaymentUnderLicenseAgreement
1000000
CY2011 us-gaap Restructuring Charges
RestructuringCharges
-740000
CY2011 vnda Lease Termination Penalty Expense
LeaseTerminationPenaltyExpense
700000
CY2004 vnda Future Percentage Of Royalty Payments Based On Net Sales
FuturePercentageOfRoyaltyPaymentsBasedOnNetSales
Low teens
CY2004 vnda Payment As Initial License Fee
PaymentAsInitialLicenseFee
500000
CY2004 vnda Percentage Of Future Sublicense Fees Payable
PercentageOfFutureSublicenseFeesPayable
Mid-twenties
CY2004 vnda Possible Future Milestone Payment
PossibleFutureMilestonePayment
Up to $37.0 million
CY2004 vnda Possible Future Milestone Payment Based On Sales Event
PossibleFutureMilestonePaymentBasedOnSalesEvent
25000000
CY2012 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P8Y
CY2012 us-gaap Payments For Restructuring
PaymentsForRestructuring
1507000
CY2012 us-gaap Restructuring Charges
RestructuringCharges
-1220000
CY2012 vnda Lease Exit Liability
LeaseExitLiability
1300000
CY2012 vnda Lease And Rental Expense From Ceasing Lease
LeaseAndRentalExpenseFromCeasingLease
800000
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.19
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.19
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28226743 shares
CY2012Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
shares
CY2012Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5150778 shares
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28226743 shares
CY2012Q3 us-gaap Sales Revenue Net
SalesRevenueNet
8288000
CY2012Q3 us-gaap License And Services Revenue
LicenseAndServicesRevenue
6753000
CY2012Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
18000
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5326000
CY2012Q3 us-gaap Other Income
OtherIncome
69000
CY2012Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5308000
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5395000
CY2012Q3 us-gaap Royalty Revenue
RoyaltyRevenue
1535000
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-5326000
CY2012Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
18000
CY2012Q3 us-gaap Costs And Expenses
CostsAndExpenses
13683000
CY2012Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3147000
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2012Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
CY2012Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
377000
CY2012Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
576000
CY2012Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
200000
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10159000
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31332993 shares
CY2013Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
shares
CY2013Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3801651 shares
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31332993 shares
CY2013Q3 us-gaap Sales Revenue Net
SalesRevenueNet
8709000
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5711000
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2013Q3 us-gaap License And Services Revenue
LicenseAndServicesRevenue
6753000
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5380000
CY2013Q3 us-gaap Other Income
OtherIncome
25000
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5380000
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5405000
CY2013Q3 us-gaap Royalty Revenue
RoyaltyRevenue
1956000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-5380000
CY2013Q3 us-gaap Costs And Expenses
CostsAndExpenses
14114000
CY2013Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
CY2013Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
377000
CY2013Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1495000
CY2013Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
300000
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8026000

Files In Submission

Name View Source Status
0001193125-13-433952-index-headers.html Edgar Link pending
0001193125-13-433952-index.html Edgar Link pending
0001193125-13-433952.txt Edgar Link pending
0001193125-13-433952-xbrl.zip Edgar Link pending
d591280d10q.htm Edgar Link pending
d591280dex311.htm Edgar Link pending
d591280dex312.htm Edgar Link pending
d591280dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vnda-20130930.xml Edgar Link completed
vnda-20130930.xsd Edgar Link pending
vnda-20130930_cal.xml Edgar Link unprocessable
vnda-20130930_def.xml Edgar Link unprocessable
vnda-20130930_lab.xml Edgar Link unprocessable
vnda-20130930_pre.xml Edgar Link unprocessable